Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

被引：0
|
作者：
Sheng Li
Liangjun Zhu
Li Yao
Lei Xia
Liangxi Pan
机构：
[1] Jiangsu Tumor Hospital,Oncology
[2] First Hospital Affiliated to Suzhou University,Department of Hematology
[3] Jiangsu Tumor Hospital,Department of Pathology
来源：
BMC Gastroenterology | / 14卷
关键词：
Colorectal cancer; ERCC1; TS; Real-time PCR; Adjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy
    P Li
    Y J Fang
    F Li
    Q J Ou
    G Chen
    G Ma
    British Journal of Cancer, 2013, 108 : 1238 - 1244
  • [22] Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term
    Chen, Liqi
    Li, Guoli
    Li, Jieshou
    Fan, Chaogang
    Xu, Jian
    Wu, Bo
    Liu, Kun
    Zhang, Caihua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 921 - 928
  • [23] Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term
    Liqi Chen
    Guoli Li
    Jieshou Li
    Chaogang Fan
    Jian Xu
    Bo Wu
    Kun Liu
    Caihua Zhang
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 921 - 928
  • [24] 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer
    Di Paolo, Antonello
    Lencioni, Monica
    Amatori, Feclerica
    Di Donato, Samantha
    Bocci, Guido
    Orlandini, Cinzia
    Lastella, Marianna
    Federici, Francesca
    Iannopollo, Mauro
    Falcone, Alfredo
    Ricci, Sergio
    Del Tacca, Mario
    Danesil, Romano
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2749 - 2755
  • [25] 5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients
    Di Paolo, Antonello
    Lencioni, Monica
    Amatori, Federica
    Di Donato, Samantha
    Federici, Francesca
    Bocci, Guido
    Falcone, Alfredo
    Ricci, Sergio
    Del Tacca, Mario
    Danesi, Romano
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels:: Predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil
    Kornmann, M
    Schwabe, W
    Sander, S
    Kron, M
    Sträter, J
    Polat, S
    Kettner, E
    Weiser, HF
    Baumann, W
    Schramm, H
    Häusler, P
    Ott, K
    Behnke, D
    Staib, L
    Beger, HG
    Link, KH
    CLINICAL CANCER RESEARCH, 2003, 9 (11) : 4116 - 4124
  • [27] Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
    Gamelin, EC
    DanquechinDorval, EM
    Dumesnil, YF
    Maillart, PJ
    Goudier, MJ
    Burtin, PC
    Delva, RG
    Lortholary, AH
    Gesta, PH
    Larra, FG
    CANCER, 1996, 77 (03) : 441 - 451
  • [28] Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy
    Deng, Wenying
    Jiao, Nanlin
    Li, Ning
    Wan, Xiangbin
    Luo, Suxia
    Zhang, Youwei
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 73 : 1 - 5
  • [29] Evaluation of thymidylate synthase and ERCC1 mRNA levels as predictive markers in colorectal cancer patients treated with S-1 and oxaliplatin
    Kuramochi, H.
    Hayashi, K.
    Nakajima, G.
    Kamikozuru, H.
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Associations between epidermal growth factor receptor polymorphism and survival in colorectal cancer patients treated with 5-FU based adjuvant chemotherapy
    Lai, Ching-Yu
    Sung, Fung-Chang
    Hsieh, Ling-Ling
    Tang, Reiping
    Yeh, Chih-Ching
    CANCER RESEARCH, 2011, 71
12345